Percentage of Patients with Pituitary Stalk Thickening in Patients With or Without Mismatch at Disease Onset and During Follow-Up
| . | Mismatch . | P . | |
|---|---|---|---|
| . | Yes . | No . | . |
| Pituitary stalk thickening | |||
| At onset: yes | 17/21 (81.0%) | 10/18 (55.6%) | 0.09# |
| no | 4/21 (19.0%) | 8/18 (44.4%) | |
| At 6 months: progressed | 7/21 (33.3%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 10/21 (47.6%) | 11/18 (61.1%) | |
| decreased | 4/21 (19.0%) | 5/18 (27.8%) | |
| At 12 months: progressed | 5/21 (23.8%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 14/21 (66.7%) | 16/18 (88.9%) | |
| decreased | 2/21 (9.5%) | 0/18 (0.0%) | |
| At 18 months: progressed | 1/21 (4.8%) | 0/18 (0.0%) | 0.03§ |
| unchanged | 13/21 (61.9%) | 17/18 (94.4%) | |
| decreased | 7/21 (33.3%) | 1/18 (5.6%) | |
| . | Mismatch . | P . | |
|---|---|---|---|
| . | Yes . | No . | . |
| Pituitary stalk thickening | |||
| At onset: yes | 17/21 (81.0%) | 10/18 (55.6%) | 0.09# |
| no | 4/21 (19.0%) | 8/18 (44.4%) | |
| At 6 months: progressed | 7/21 (33.3%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 10/21 (47.6%) | 11/18 (61.1%) | |
| decreased | 4/21 (19.0%) | 5/18 (27.8%) | |
| At 12 months: progressed | 5/21 (23.8%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 14/21 (66.7%) | 16/18 (88.9%) | |
| decreased | 2/21 (9.5%) | 0/18 (0.0%) | |
| At 18 months: progressed | 1/21 (4.8%) | 0/18 (0.0%) | 0.03§ |
| unchanged | 13/21 (61.9%) | 17/18 (94.4%) | |
| decreased | 7/21 (33.3%) | 1/18 (5.6%) | |
# P: Chi-square test; §P: Fisher exact test.
Percentage of Patients with Pituitary Stalk Thickening in Patients With or Without Mismatch at Disease Onset and During Follow-Up
| . | Mismatch . | P . | |
|---|---|---|---|
| . | Yes . | No . | . |
| Pituitary stalk thickening | |||
| At onset: yes | 17/21 (81.0%) | 10/18 (55.6%) | 0.09# |
| no | 4/21 (19.0%) | 8/18 (44.4%) | |
| At 6 months: progressed | 7/21 (33.3%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 10/21 (47.6%) | 11/18 (61.1%) | |
| decreased | 4/21 (19.0%) | 5/18 (27.8%) | |
| At 12 months: progressed | 5/21 (23.8%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 14/21 (66.7%) | 16/18 (88.9%) | |
| decreased | 2/21 (9.5%) | 0/18 (0.0%) | |
| At 18 months: progressed | 1/21 (4.8%) | 0/18 (0.0%) | 0.03§ |
| unchanged | 13/21 (61.9%) | 17/18 (94.4%) | |
| decreased | 7/21 (33.3%) | 1/18 (5.6%) | |
| . | Mismatch . | P . | |
|---|---|---|---|
| . | Yes . | No . | . |
| Pituitary stalk thickening | |||
| At onset: yes | 17/21 (81.0%) | 10/18 (55.6%) | 0.09# |
| no | 4/21 (19.0%) | 8/18 (44.4%) | |
| At 6 months: progressed | 7/21 (33.3%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 10/21 (47.6%) | 11/18 (61.1%) | |
| decreased | 4/21 (19.0%) | 5/18 (27.8%) | |
| At 12 months: progressed | 5/21 (23.8%) | 2/18 (11.1%) | 0.30§ |
| unchanged | 14/21 (66.7%) | 16/18 (88.9%) | |
| decreased | 2/21 (9.5%) | 0/18 (0.0%) | |
| At 18 months: progressed | 1/21 (4.8%) | 0/18 (0.0%) | 0.03§ |
| unchanged | 13/21 (61.9%) | 17/18 (94.4%) | |
| decreased | 7/21 (33.3%) | 1/18 (5.6%) | |
# P: Chi-square test; §P: Fisher exact test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
